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Abstract 
Immunoprecipitated plOOGag-Mil protein kinase from MH2-transformed quail embryo fibroblasts is associated with an 89 kDa protein. The molar 
ratio between p89 and Gag-Mil in the immunocomplex is0.72, indicating that the majority of Gag-Mil is complexed with ~89. During mitosis part 
of Gag-Mil is shifted to a form with reduced electrophoretic mobility, plOZGag-Mil. Appearance of plOZGag-Mil leads to a reduced association with 
p89 indicating that ~102 is not associated with ~89. Microsequencing of p89 isolated from immunoprecipitates of Gag-Mil identified the protein as 
the quail homologue of chicken hsp90. Our results show that plOOGag-Mil is associated with hsp90 with a high stoichiometry and that upshifted 
plO2Gag-Mil is released from the complex with hsp90. 
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1. Introduction 
MH2 is an acutely transforming virus encoding two 
oncogene proteins: Gag-Mil and v-Myc [l]. Infection 
with the virus leads to carcinoma in chickens and both 
oncogenes contribute to the transforming potential of 
the virus [2]. The Mil portion of the Gag-Mil fusion 
protein is homologous to the carboxyterminus of c-Mil, 
the avian counterpart of the mammalian c-Raf-1 [3]. 
Gag-Mil is, like c-Raf-1, a serine-threonine specific pro- 
tein kinase [4]. c-Raf-1 can be devided into a regulatory 
aminoterminus and a carboxyterminus with intrinsic ki- 
nase activity. c-raf is thought to gain transforming poten- 
tial through loss of regulatory sequences encoded in the 
aminoterminal part of the protein rather than being acti- 
vated through point mutations. Point mutations are rare 
and not conserved between different viruses carrying ho- 
mologous sequences [5]. Indeed consecutive deletions in 
the aminoterminal half of the kinase enhance the trans- 
forming potential of the resulting proteins [6]. The mini- 
mal portion of the protein with the highest transforming 
potential is represented by v-Raf, the transforming prin- 
ciple of 3611, a murine leukemia virus. However, in the 
case of Gag-Mil, the Mil portion still contains part of the 
regulatory region of c-Mil [5]. ’ 
tion for several years the molecular mechanisms of their 
action is still obscure. Lately a first in vivo substrate for 
the c-Raf-1 kinase has been discovered and shown to be 
associated with the carboxyterminus of c-Raf-1 [7]. Re- 
cent evidence [I?] reveals a role for c-Raf-1 in meiosis of 
Xenopus oocytes and there is one report linking c-Raf-1 
to later events in the cell cycle [9]. However, in the past, 
work has focussed on the activation of c-Raf-1 in G, 
following application of various mitogens [lo]. c-Raf-1 
is an essential intermediate between cell stimulation and 
proliferation [l 11. c-Raf-1 activation leads to hyper- 
phosphorylation and activation of the kinase while the 
viral Mil/Raf proteins are thought to be constitutively 
active. Major progress in linking cell stimulation and 
proliferation has been made by the discovery of physical 
interaction between activated Ras and c-Raf-1 [12]. 
In order to identify proteins associated with Mil/Raf 
proteins in vivo, we made use of MH2-transformed quail 
fibroblasts to co-immunoprecipitate associated proteins. 
In our study we show the isolation of one such protein 
with an A4, of 89 kDa and its identification as hsp90. 
Furthermore our data clearly demonstrate that the asso- 
ciation between Gag-Mil and hsp90 is cell cycle-depend- 
ent. 
Viral Mil/Raf proteins are implicated in various neo- 
plasms [5] and although they have been under investiga- 2. Materials and methods 
2.1. Cells and cell culture conditions 
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All cells were cultured at 37°C in a water-saturated atmosphere 
containing 7% CO*. MHZ-transformed quail fibroblasts [13] and 
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tion of quail fibroblasts with MC29 virus, were cultured in 47% 
DME~47% RPMI/S% FCS/l% chicken ~~0.5% DMSO sut~ule- 
mented with 50 mM HEPES and 1.5 g!l tryptose phosphate broth 
(DIFCO) containing penicillin (70 units/ml) and streptomycin 0.1 mg/ 
ml). Rat1 cells and Ratl-derived cell lines were cultured in DMEM 
containing 10% FCS and antibiotics. To obtain cell lines that stably 
express the carboxvtermial half of hu-c-Raf, Rat1 cells were transfected 
wGh pMAMneoB_LUEcRafCT (G. Radziwill, unpublished) and se- 
lected with 0.8 &ml G418. nMAMneoBLUEcRafCT allows Dexa- 
methasone-induiable expression of hu-c-Raf-1 from amino acid 322 to 
648 (c-RafCT). Clones were checked for expression of c-RafCT by 
immunoprecipitation of [“S]methionine metabolically labelled cells 
with appropriate antibody and the clone RatlRCT was chosen for 
further analysis. For metabolic label&g, exponentally growing cultures 
were washed twice with PBS and cultured for 3 h in methionine-free 
DMEM (ICN FLOW} containing 10% dialysed FCS and 150 &i/ml 
Tra#S-label (ICN FLOW). For s~e~on~tion of cells at different 
phases of the cell cycle exponentially growing cultures were treated for 
17 h with Aphidicholine (G, phase) [15], arrested by double Thymidine 
block (S phase} 1161, or treated for 10 h with 0.05 &ml Nocodazole 
(M phase) [17] prior to harvesting. To control for synchronization, 
1 x lo5 cells were analyzed for DNA content after propidium iodide 
staining with a FACScan (Becton-Dickinson) using CellFIT software. 
All cell culture materials were obtained from Gibeo. 
2.2. Antibodies and immunoprecipitation 
Antiserum directed against the carboxyterminal peptide 
CTLTTSPQSPVF of hu-c-Raf-1 was obtained following immunization 
of rabbits with BSA-coupled peptide. As&tic fluid of the previously 
described hybridoma producing Gag-specific antibody, fl4f was pre- 
pared for i~~opr~ipitation. A Myc-specific rabbit serum was pre- 
pared using a MS2-Myc fusion protein as antigen [I 81. For immunopre- 
iipitation of interphase cells, c&mm were washed twice with PBS&d 
lvsed in RIPA buffer (20 mM Tris DH 7.5.137 mM NaCl. 2 mM EDTA. 
<O% glycerol, 0.1% SDS, 0.5% Na deoiycholate, 1% ‘l&ton X-100, 1 
mM PMSF, 20 U/ml Trasylol (Bayer), 1 &ml leupeptin (Sigma), 1 
,@nl ribonuclease A, 50 mM 2glycerolphosphate, 50 mM NaF, 1 mM 
NaVO,] yielding 1 ml lysate per 1 x lo’cells. For each lane 5 x lo6 cells 
were immunoprecipitated. The same buffer containing 50 mM NaCl, 
0.5% Nomdet-P-40,0.5% SDS without Triton X-100 was used for cell 
lysis under denaturating conditions. Nocodazole-treated cells were har- 
vested by gently shaking the culture plates and pelleted at 800 x g prior 
to washing with PBS. Lysates were preadsorbed with 5% volume of 
protein A Sepharose (Pharmacia) for 30 min and spun down for 30 min 
at 11,000 x g. Supernatants were incubated for 2 h with 3 yl antiserum 
or as&tic fluid prebound to protein A Sepharose. In competition exper- 
iments this step was performed either in the presence of 10 pg/ml 
car~x~e~in~ Raf peptide or MSZ-Myc protein. ~0~~~ im- 
munocomplexes were washed 5 times with lysis buffer, SDS sample 
buffer was added and samples were incubated 3 min at 95°C prior to 
separation on 10% SDS polyacrylamide gels. For visualization of pre- 
cipitated proteins, gels were either fluorographed with Kodak intensify- 
ing screens at -70°C using preflashed films or silver stained HP]. Gels 
with 35S-labelled samples were quantified on a Phosphorimager (Molec- 
ular Dynamics), stained gels on a Personal Densitometer (Molecular 
Dynamics) using BSA as standard. 
2.3. Protein sequence analysis 
In order to obtain enough materia1 for microsequencing, im- 
munonrecimtation was scaled up. A total of 1 x 109 MH2-transformed 
quail fibroblasts was ~~op~~pi~t~ with Gag-specific antibody, 
subjected to SDS-PAGE and ~89 was eluted from Coomassie (Servaf 
stained gels [ZO]. The pooled ebtates were TCA precipitated, separated 
again by gel electrophoresis and blotted to PVDF membrane (Mil- 
lipore). p89 excised from Ponceau S (Sigma) stained membranes was 
cleaved by endoproteinase Lys C and processed for protein sequencing 
essentially as described [21]. in brief, unsaturated protein binding sites 
of the membrane were blocked with a solution containma 0.5% PVP-40 
and 40% methanol, washed and digested in a buffer contiining 100 mM 
Tris-HCl pH 8.5, 10% Acetonitril and 1% hydrogenated Triton X-100. 
0.48 units of endoproteinase Lys C (Boehringer) were added to cleave 
6 pg p89 bound to the membrane. After incubation for 16 h at 37°C 
resulting peptides were eluted from the membrane in digestion buffer 
with 0.1% TFA. The resulting peptides were seperated on a pRPC 
C2/C18 SC 2.1/10 ~ha~acia) column using the Smart TM System 
~ha~a~a). The column was nm at a flow rate of 0.5 ml/min employ- 
ing an aqueous gradient of Acetonitril in 0.1% TFA: O-5 min, 0%; 5-60 
min, 40%; 60-100 min, 80%; lOC-105 mm, 90%; 105-120 min, 90%. 
Sequence analysis of the indicated peptides was carried out using a 
pulsed liquid gas phase sequencer model 47719 equipped with a model 
120A PTH-aminoacid analyser (Applied Biosystems). 
Computer aided searches~and ali@ments were performed on a VAX/ 
VMS 8600 svstem in the Protein Identitication Resource databank 
release 25 (National Biomedical Research Foundation) and the Swiss- 
prot databank using FASTA programme [22] of GCG7 [23]. 
3. Results 
3.1. Association of ~iil~~f p~~te~~ with p&9 
MH2-transform quail embryo fibroblasts express 
the oncogene fusion protein plOOGag-Mil[14]. On anal- 
ysis of immunoprecipitates of plOOGag-Mil with MU 
Raf-specific carboxyterminal peptide antibody several 
coprecipitating proteins from cells lysed under native 
conditions are detected in silver stained gels (Fig, 1A). 
Competition of the antibody with its cognate peptide 
antigen removes plOOGag-Mil and a protein with the n/r, 
of 89 kDa from the immunoprecipitates. A second inde- 
pendently derived antibody directed against the amino- 
terminus of the viral pl9Gag also precipitates both pro- 
teins. No coprecipitating proteins are observed with both 
antibodies under more stringent lysis conditions (Fig. 1A 
and data not shown). 
To ensure that the observed coprecipitation is medi- 
ated by the carboxy terminus of plOOGag-Mil and not 
by the Gag moiety immunoprecipitation of another Gag- 
fusion protein was performed, pl lOGag-Myc from 
MC29-transformed quail fibroblasts. It was immunopre- 
cipitated in parallel to plOOGag-Mil under native lysis 
conditions with both, Myc- and Gag-specific antibodies. 
Prior to lysis cells were metabolic~ly labelled with 
~3sS~et~onine to allow more sensitive detection of co- 
precipitated proteins. Although a strong band of 
pl lOGag-Myc is detectable in fluorographs no specifi- 
cally coprecipitating 89 kDa protein could be visualised, 
while p 1 OOGag-Mil-associated p89 was readily detecta- 
ble (Fig. 1B). 
In order to assess whether association with p89 is a 
conserved feature among MiYRaf proteins a cell line 
(Rat 1 RCT) was established expressing the carboxyter- 
minal half of human c-Raf-1 (c-RafCT). In the parental 
cell line (Ratl) the amount of c-Raf-1 is too low to allow 
detection of associated proteins in i~unopr~ipitates 
(Fig. 1C). In RatlRCT expression level of c-RafCT is 
enhanced about sevenfold compared to c-Raf-l . Compe- 
tition of the Raf-specific antiserum leads to the specific 
disappearance of c-Raf- 1, c-RafCT (M, = 38 kDa), sev- 
eral minor proteins with M, between 39 and 29 kDa and 
a ~89 from immunoprecipitates (Fig. 1C). In contrast to 
~89 the proteins with M, between 39 and 29 kDa also 
appear in immunoprecipitates performed under denatu- 
rating lysis conditions identifying these as splice variants 
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Fig. 1. Association of Gag-Milk-RafCT with p89. (A) MH2-transformed quail fibroblasts were immunoprecipitated under native @at.) or denatu- 
rating (den.) lysis conditions using as antibody (Ab) Raf- specific peptide serum (a-R4 or a monoclonal antibody against p19 Gag (a-Gag). 
Competition (camp.) was performed using the appropriate peptide in excess to saturate the antibody. The precipitates were separated by SDS-PAGE 
and silver stained as described in section 2. (B) Equal numbers of MHt-transformed quail fibroblasts or MC29Q8NP cells were labelled metabolically 
with [35S]met~on~e, ~~op~cipi~ted and separated on an SD~~lya~la~de gel. Myc- specific antibody (a-Myc) was competed with excess 
of MS2-Myc fusion protein, A fluoro~aph of the dried gel is shown. (C) Same as in (B), except hat Rat1 and a Rat1 derived cell line (RatlRCT) 
stably transfected with the c~box~e~al moiety of c-Raf-1 (c-RafCT’j were ~~opr~ipita~ either with Raf-specitic or unrealated control 
antibody (cont.). Cells were stimulated with 1 x 10V7 M Dexamethasone at the beginning of metabolic labelling. 
or aminoterminal degradation products of c-RafCT, 
while ~89 is absent from immunoprecipitates under such 
conditions (data not shown). ~89 is also absent from 
immunoprecipitates with unrelated control antibody 
(Fig. 1C). 
3.2. Cell cycle-dependent ass~c~a~i~n of Gag-Ml and p&9 
Although the action of c-Raf-1 is well estab~shed dur- 
ing G,-phase there is evidence suggesting a role for MiU 
Raf proteins in later phases of the cell cycle [9]. Therefore 
we investigated the association of Gag-Mil and ~89 in 
populations of cells enriched at different stages of the cell 
cycle. Cells synchronized at G,- or S-phase showed no 
obvious differences compared to unsynchronized cells in 
immunoprecipitates of Gag-Mil (data not shown). How- 
ever, after enrichment of cells in M phase of the cell cycle 
a different relative mobility of Gag-Mil as well as a low- 
ered stoichiometry of association between Gag-Mil and 
p89 were observed (Fig. 2A and C). Irrespective of the 
protocol used for synchronization, either transiently by 
means of release from double thymidine block in S-phase 
(data not shown) or stationary by means of Nocodazole 
block in M-phase (Fig. 2A), a more slowly migrating 
form of Gag-Mil with an iw, of 102 kDa appeared (Fig. 
2A). ~102 was detected by means of silver staining in 
~unoprecipi~tes of both Gag-Mil-specific antibod- 
ies. Appearance of ~102 was also observed in im- 
munoprecipitates obtained under denaturating lysis con- 
ditions and in Western blot analysis of whole cell lysate 
(data not shown). In both cases precence of ~102 was 
abolished by competing the antibody with its cognate 
antigen. ~102 and plOOGag-Mil derived from [32P]ortho- 
phosphate metabolically labelled cells show identical 
phosphopeptides in two-dimensional peptide maps 
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Fig. 2. Association of Gag-Mil and p89 is cell cycle-dependent. (A) Exponentially growing interphase (Int) or Nocodaxole-treated (Noco) MH2- 
transformed quail fibroblasts were immunoprecipitated under native conditions as in Fig. 1A. Positions of p89, plOOGag-Mil and the mitosis-specific 
plOZGag-Mil are indicated on the right. (B) FACS- analysis of the DNA content from MHZ-transformed quail fibroblasts cultured in parallel with 
the cells used in (A). 2n and 4n indicate the ploidity of the cells. (C andD) Quantification of four independent assays similar to the one shown in 
(A). Results are shown as means *standard errors of four independent assays. Indicated are the molar ratios of plOOGag-Mil (open boxes), 
pl02Gag-Mil (hatched boxes), or p89 (black boxes) to total Gag-Mil @lOOGag-Mil in addition to plOZGag-Mil) present in the immunoprecipitates. 
Boxes in D indicate molar ratios of p89 to plOOGag-Mil present in immunoprecipitates. 
3.3. IdentiJication of p89 as hsp90 
To further characterize the 89 kDa coprecipitating 
protein we took advantage of the fact that it was present 
in relatively high amounts in immunoprecipitates of 
plOOGag-Mil. About 40 ng of p89 were isolated from 
immunoprecipitates of 5 x lo6 cells (Fig. 1A). Further- 
more, no contaminations by other cellular proteins with 
the same M, as p89 were detectable after competition of 
the antibody (Fig. 1A). In order to obtain enough mate- 
rial to allow microsequencing of the protein, im- 
munoprecipitation was scaled up. p89 was eluted from 
gels loaded with immunoprecipitates from lysates corre- 
sponding to lo9 MHZtransformed quail fibroblasts. The 
amount of p89 recovered was about 11 ,ug in total. Be- 
cause of aminoterminal blockage towards Edman degra- 
dation (data not shown), part of the protein (6 pg) was 
digested by endoproteinase Lys C. The resulting peptides 
(manuscript in preparation). From these properties of 
~102 we conclude that it is indeed a modified form of 
plOOGag-Mil and name it therefore pl02Gag-Mil. 
In interphase cells where almost all of Gag-Mil is pres- 
ent as ~100, p89 and Gag-Mil are associated in a molar 
ratio of 0.72. In cells enriched for mitosis the molar ratio 
of p89 versus total Gag-Mil (~100 and ~102) in the im- 
munoprecipitates is lowered to 0.35 (Fig. 2C). This 
means that association is lowered to 48% of the value 
observed in interphase cells. At the same time the frac- 
tion of Gag-Mil present as ~100 is lowered from 93% in 
interphase cells to 46% in Nocodazole-treated cells. 
Therefore, if one calculates the molar ratio between p89 
and plOOGag-Mil present in immunocomplexes the 
value is identical between interphase cells and cells en- 
riched in mitosis (Fig. 2D), indicating that the mitosis- 
specific pl02Gag-Mil is not associated with p89. 
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were separated by Microbore HPLC chromatography 
and two of them were sequenced on an automated se- 
quencer (Fig. 3A). Computer-aided search for homology 
to the obtained sequences was carried out. A 100% 
match to chicken and human hsp90 was found for the 20 
amino acid strech present on the sequenced peptides 
(Fig. 3B). We therefore conclude that the 89 kDa protein 
associated with Gag-Mil in a cell cycle-specific manner 
is the quail homologue of chicken hsp90. 
4. Discussion 
Association of Mil/Raf proteins with other proteins 
was observed at two points of Mil/Raf action; in the 
course of kinase activation [12] and during substrate 
phosphorylation [7]. In order to isolate new Mil/Raf as- 
sociated factors we used a rather direct approach trying 
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Fig. 3. Protein sequence analysis of p89. (A) Peptide map of p89 gener- 
ated by digestion with endoproteinase Lys C and separation by HPLC. 
The peptides A and B were used for aminoterminal sequence determi- 
nation. (B) The obtained sequences of peptide A and B were aligned 
to the amino acid sequence of chicken hsp90. The identity of underlined 
residues was deduced from the sequence specificity of Lys C, indicated 
by arrows. 
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to coimmunoprecipitate these proteins. To obtain 
enough material to characterize associated proteins we 
employed the naturally occurring system of Gag-Mil 
overexpression in MHZtransformed quail fibroblasts. 
These cells express plOOGag-Mil in an amount up to 
0.015% of total cellular protein (J. Lovric, unpublished 
observation). In this study we describe the isolation of 
p89, the most abundant coprecipitating protein in Gag- 
Mil immunoprecipitates. Furthermore we show that its 
association with Gag-Mil is cell cycle-dependent and 
identify p89 as hsp90. 
Co-immunoprecipitation of p89 and plOOGag-Mil is 
observed with both aminoterminal and carboxyterminal 
antibodies and is abolished by competing the antibody 
or by more stringent lysis conditions (Fig. lA), indicat- 
ing that p89 is a specifically associated protein rather 
than a degradation product of plOOGag-Mil. In 
MC29Q8NP the Mil-specific antibody did not precipi- 
tate relevant amounts of proteins with a h4, of 89 (data 
not shown) and precipitates of pl lOGag-Myc also do not 
show significant amounts of such proteins (Fig. 1 B). The 
lower amount of immunoprecipitable pl lOGag-Myc 
compared to plOOGag-Mil is in part due to the strong 
DNA binding of Myc [25]. However, under conditions 
which release Gag-Myc from DNA, no association be- 
tween Gag-Mil and p89 is detectable (Fig. lA, first lane). 
c-RafCT, which is homologous to part of the Mil se- 
quences in plOOGag-Mil, also associates with a p89 in 
Rat1 cells. Taken together these data represent strong 
evidence for an association of p89 and the catalytic do- 
main of Mil/Raf proteins in vivo. The detection of the 
associated proteins by silver staining allows a reliable 
estimate of the ratio of p89 versus plOOGag-Mil in im- 
munoprecipitates. Aminoterminal and carboxyterminal 
antibodies result in the same high stoichiometry of asso- 
ciation, rendering it unlikely that the antibodies prefer 
binding to p89-associated Gag-Mil rather than to un- 
bound Gag-Mil. If one assumes a 1: 1 ratio of Gag-Mil 
and p89 in the complex and the possibility that part of 
the p89 is released from the complex during immunopre- 
cipitation, then most if not all of the plOOGag-Mil pres- 
ent in interphase cells is associated to p89. Note that the 
stoichiometry of association between p89 and plOOGag- 
Mil detectable in metabolically labelled cells (Fig. 1B) 
compared to direct staining of immunocomplexes (Fig. 
1A) is lowered from 0.72 to about 0.15. This is probably 
caused by differences in protein synthesis rates during 
the labelling time of 3 h and differences of in vivo protein 
half-lives between p89 and Gag-Mil. An increase of sto- 
ichiometry to about 0.3 is achieved after metabolically 
labelling of cells with [35S]methionine for 10 h (data not 
shown). 
In mitotic cells the appearance of pl02Gag-Mil corre- 
lates with a lower stoichiometry of association to p89. 
The portion of Gag-Mil appearing as ~102 varied from 
40% up to 65% of the total Gag-Mil in four independent 
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assays (Fig. 2C). These changes correlate with changes 
in molar ratios of p89 versus total Gag-Mil between 0.4 
and 0.32 compared to 0.72 in interphase cells. No 
changes occur if one estimates the ratio of p89 versus 
plOOGag-Mil in immunoprecipitates of either mitotic or 
interphase cells (Fig. 3D). These results can be explained 
most easily by assuming that only plOOGag-Mil is asso- 
ciated with p89 and not the modified pl02Gag-Mil. 
Longer exposure of cells to Nocodazole leads to higher 
enrichment of mitotic cells with blocked mitotic spindles 
[17] and might therefore enhance the observed changes 
but it also lowers yields of Gag-Mil in immunoprecipita- 
tions (data not shown). This is probably due to degrada- 
tion of Gag-Mil during prolonged M phase and the 10 
h exposure to Nocodazole is a compromise in order to 
obtain enough mitotic cells with only modestly prolong- 
ing the M phase which has a duration of l-2 h in an 
undisturbed cell cycle. During mitosis, cells round up 
and detach from the substratum. To rule out the possibil- 
ity that the observed effects are simply due to loss of 
contact to the substratum cells were incubated in PBS 
without MgZ’ and Ca2’. This treatment also leads to cells 
detached from the substratum. However, in these cells no 
changes in electrophoretic mobility of Gag-Mil or in 
association to p89 occurred (data not shown). 
The sequenced peptides of p89 show 100% identity to 
chicken- and human hsp90 and p89 is therefore con- 
cluded to be the quail homologue of chicken hsp90 (Fig. 
3B). Because of the relatively high abundance of hsp90 
one might assume that it is present rather unspecifically 
in the immunoprecipitates and accumulated uring isola- 
tion of p89. However, there are no contaminating pro- 
teins in the region of p89 migration on SDS poly- 
acrylamide gels after competition of the antibody (Fig. 
1A). Because of the low amount of protein used for 
sequencing, remaining contaminations from background 
proteins with identical electrophoretic mobility could not 
have led to any readable sequence. 
While this work was under way L.F. Stancato and 
coworkers [26] showed the association of carboxytermi- 
nal Raf sequences with hsp90 by means of coim- 
munoprecipitation followed by hsp90-specific Western 
blot analysis. Our results support these findings and ex- 
tend them in important aspects, namely by quantifying 
the molar ratios of the components and by demonstrat- 
ing the high stability of the complex. Furthermore, we 
show that association of hsp90 and Gag-Mil is cell cycle- 
dependent. Further work is under way in order to inves- 
tigate association of other Raf proteins and hsp90 during 
the cell cycle by means of coimmunoprecipitation fol- 
lowed by hsp90-specific Western blot. 
hsp90 has been shown to associate with steroid 
hormone receptors and pp60’+“. In the case of ~~60”~“” 
hsp90 is only transiently associated with the inactive ki- 
nase and has been implicated in cytosolic trafficking 
while the active, thyrosine phosphorylated and mem- 
brane anchored pp60’+” is not associated with hsp90. 
However, transformation-deficient mutants of pp60’+” 
are stably associated with hsp90 [27]. Furthermore, it is 
well established that pp60”-“” is activated during mitosis 
[28]. Our results indicate that there might be some paral- 
leles in kinase activation and in association to hsp90 
between ~~60”” and MiYRaf proteins. Activation of c- 
Raf- 1 kinase activity leads to hyperphosphorylation and 
decreased mobility of the kinase in SDS polyacrylamide 
gels [29]. A decreased mobility of c-Raf-1 in SDS gels is 
also observed in mitotic cells ([9] and manuscript in prep- 
aration). We also observe a decreased mobility of Gag- 
Mil in mitotic cells. In parallel to c-Raf-1, this mobility 
shift presumably results from an activation of the kinase 
and is accompanied by release of Gag-Mil from hsp90 
association, as in the case of pp60’““. Furthermore it 
holds true for both proteins that their cellular counter- 
parts c-Raf-1 and pp60”“” are not observed in stable 
association with hsp90 without being overexpressed 
[26,30]. This could reflect either intrinsic differences be- 
tween the oncogene products and their cellular counter- 
parts or be a result of the low abundance of pp60”+” and 
c-Raf- 1. Further investigation of c-Raf- 1 kinase activity 
and association with hsp90 will clearly be helpful in an- 
swering the question whether hsp90 plays a more general 
role in kinase activation and/or cytosolic trafficking of 
kinases. 
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